Shares of health-care companies rose after strong earnings from one fallen giant.
Shares of Valeant Pharmaceuticals International surged after the specialty drug maker's third-quarter revenue surpassed Wall Street targets and as it made progress on debt management.
Continue Reading Below
Shares of Indian generic-drug maker Lupin fell sharply after the company said it got Food and Drug Administration warning letters regarding plant conditions.
-Rob Curran, email@example.com
(END) Dow Jones Newswires
November 07, 2017 16:50 ET (21:50 GMT)